標(biāo)題: Titlebook: Biomarkers in Liver Disease; Victor R. Preedy Living reference work 20200th edition [打印本頁] 作者: dentin 時(shí)間: 2025-3-21 17:31
書目名稱Biomarkers in Liver Disease影響因子(影響力)
書目名稱Biomarkers in Liver Disease影響因子(影響力)學(xué)科排名
書目名稱Biomarkers in Liver Disease網(wǎng)絡(luò)公開度
書目名稱Biomarkers in Liver Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biomarkers in Liver Disease被引頻次
書目名稱Biomarkers in Liver Disease被引頻次學(xué)科排名
書目名稱Biomarkers in Liver Disease年度引用
書目名稱Biomarkers in Liver Disease年度引用學(xué)科排名
書目名稱Biomarkers in Liver Disease讀者反饋
書目名稱Biomarkers in Liver Disease讀者反饋學(xué)科排名
作者: Sad570 時(shí)間: 2025-3-21 21:38
Konservative Frakturenbehandlunge liver biomarkers. Blood EVs from patients appeared to play a detrimental role contributing disease progression. Blocking blood EV elevation by pharmacological approaches afforded protection against liver damage. Circulating EVs are emerging as a rich source of new biomarkers for liver diseases.作者: Corporeal 時(shí)間: 2025-3-22 01:15 作者: DRAFT 時(shí)間: 2025-3-22 07:57
Hans-Bernd Sch?fer,Hans-Jürgen Lwowskiis between 1 and 8 months. Due to the fact that liver cells are permanently replaced, there is always some ALAT detectable in the bloodstream. An elevation of ALAT of 15 times above ULN has a 100?% sensitivity for a liver disease.作者: 廣大 時(shí)間: 2025-3-22 11:27 作者: 無能性 時(shí)間: 2025-3-22 16:12 作者: organism 時(shí)間: 2025-3-22 17:19
https://doi.org/10.1007/978-3-322-95497-8gnosis and surveillance of HCC. In this book chapter, the focus is put on the role of serum AFP in the composition of tumor staging systems and monitoring of treatment response for clinical uses in HCC.作者: 投票 時(shí)間: 2025-3-22 21:38 作者: 縮減了 時(shí)間: 2025-3-23 03:17 作者: LAVE 時(shí)間: 2025-3-23 06:12
https://doi.org/10.1007/978-3-662-02086-9 those who would benefit the most from diagnostic, therapeutic guidance, and prognostic perspectives..In this regard, the aim of this chapter will be to examine histological biomarkers of NAFLD in order to give readers a guide about diagnosis and follow-up of this kind of disease.作者: 愛管閑事 時(shí)間: 2025-3-23 10:54 作者: 暴發(fā)戶 時(shí)間: 2025-3-23 15:09 作者: 颶風(fēng) 時(shí)間: 2025-3-23 21:59
https://doi.org/10.1007/978-3-322-95497-8s elevated in the serum of approximately 70?% of patients with HCC. Over the past five decades, AFP has been extensively studied about its role in diagnosis and surveillance of HCC. In this book chapter, the focus is put on the role of serum AFP in the composition of tumor staging systems and monito作者: 甜食 時(shí)間: 2025-3-24 00:06 作者: Inoperable 時(shí)間: 2025-3-24 02:35
,Privatheit und Intersubjektivit?t,s of patients with liver disorders. All prognostic scores for liver diseases include bilirubin in their calculations, and some studies have shown that bilirubin is an independent biomarker of mortality risk. We know that a high total bilirubin level is an indicator of disease, but nowadays there is 作者: 哀求 時(shí)間: 2025-3-24 10:21 作者: covert 時(shí)間: 2025-3-24 13:55
https://doi.org/10.1007/978-3-658-12169-300,000 in men. In terms of the absolute number of cases, almost half a million cases were reported in China, Japan, and South Korea in 2012. Worldwide, alpha-fetoprotein (AFP) testing and abdominal ultrasound (US) every 6 months are recommended for routine surveillance of HCC in high-risk patients a作者: Ordnance 時(shí)間: 2025-3-24 18:47
Hans-Bernd Sch?fer,Hans-Jürgen Lwowskiand treatment. Recurrence is the main cause of death in patients who received curative treatment for the primary cancer. Tumors arising within 2 years of treatment typically originate from the primary tumour. These recurrent tumours tend to be aggressive and result in high mortality rate for these p作者: HPA533 時(shí)間: 2025-3-24 20:02
Hans-Bernd Sch?fer,Hans-Jürgen Lwowskiit might also be detected in muscle cells. In contrast to other markers of liver cell integrity like ASAT or Lactate Dehydrogenase, ALAT is highly specific for liver diseases. The sensitivity of elevated ALAT for hepatopathies is as high as 84?% in large studies. The life span of a human liver cell 作者: 花費(fèi) 時(shí)間: 2025-3-25 01:34
Resharping the European Securities Industried accumulation of extracellular matrix proteins, ultimately leading to loss of organ function. The extracellular matrix consists of fibrous and nonfibrous macromolecules such as collagens, elastin, and proteoglycans..During progressive fibrosis the balance of extracellular matrix remodeling is alter作者: Detain 時(shí)間: 2025-3-25 04:01
Resharping the European Securities Industriemmatory conditions, neurodegenerative diseases, diabetes mellitus, atherosclerosis, and cancer. The main mechanism of redox control relies on the cellular antioxidant response. Nevertheless, oxidative stress and oxidative damage to biomolecules are events inherent to the process of carcinogenesis. A作者: 不要嚴(yán)酷 時(shí)間: 2025-3-25 09:22 作者: Pseudoephedrine 時(shí)間: 2025-3-25 12:15 作者: monochromatic 時(shí)間: 2025-3-25 19:27 作者: 拍翅 時(shí)間: 2025-3-25 23:24
https://doi.org/10.1007/978-3-322-97390-0 the Hypothalamus-pituitary-adrenal axis. Glucocorticoids function to maintain homeostasis both in response to normal diurnal changes in metabolism and in the face of stressful perturbations. The physiological actions of glucocorticoids are mediated by the glucocorticoid receptor that is expressed i作者: 遣返回國 時(shí)間: 2025-3-26 02:56 作者: CURB 時(shí)間: 2025-3-26 06:48
https://doi.org/10.1007/978-3-7091-3614-0ilure (ALF) in many countries, including Scotland, the USA, Sweden, Australia, and Denmark, among others. Based on United States Acute Liver Failure Study Group (ALFSG) data, about half of patients with APAP-induced ALF had consumed a (single time-point) dose that exceeded the recommended maximum da作者: ACRID 時(shí)間: 2025-3-26 08:33
,Behandlung der Menstruationsst?rungen,nt of liver transplant patients are currently under investigation, as conventional markers have limited usefulness to predict drug efficacy. The presence of graft-derived cell-free DNA (GcfDNA) in the plasma of liver transplant recipients opens up the possibility of monitoring allograft injury throu作者: HOWL 時(shí)間: 2025-3-26 13:14
https://doi.org/10.1007/978-3-662-02089-0 influences management. Histopathological staging of liver biopsy is considered the gold standard for assessment of liver fibrosis but is limited by its invasive nature, high cost, and sampling error. Hepascore is a serum model consisting of hyaluronic acid, bilirubin, alpha2-macroglobulin, gamma-gl作者: 在前面 時(shí)間: 2025-3-26 18:03
Konservative Therapie der Frauenkrankheitenlcoholic fatty liver disease (NAFLD) and fibrosis. Biomarkers, including those related to glycemia, serum lipid profiles, lipid oxidation, inflammation, and levels of enzymes reflecting hepatocellular damage (e.g., aminotransferases), may reflect liver function in diabetes. New epidemiological data 作者: 驚惶 時(shí)間: 2025-3-26 21:03
https://doi.org/10.1007/978-3-662-02086-9onic liver disease. Nonalcoholic fatty liver disease is characterized by a wide spectrum of conditions and covers a histological spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis..Liver biopsy remains the gold standard for characterizing 作者: Bereavement 時(shí)間: 2025-3-27 05:06 作者: 極力證明 時(shí)間: 2025-3-27 08:24 作者: innovation 時(shí)間: 2025-3-27 12:48 作者: Forsake 時(shí)間: 2025-3-27 15:40 作者: Stricture 時(shí)間: 2025-3-27 20:07 作者: 精密 時(shí)間: 2025-3-27 23:59 作者: semble 時(shí)間: 2025-3-28 06:05 作者: lambaste 時(shí)間: 2025-3-28 07:33
Biomarkers of Extracellular Matrix Remodeling in Liver Diseases,modeling leads to a range of formation and disease-relevant degradation products of extracellular and intracellular proteins into the circulation. These fragments may provide information about the pathogenesis of disease and serve as serological biomarker targets. Clinically there is a need to ident作者: emulsify 時(shí)間: 2025-3-28 10:57
Biomarkers of the Antioxidant Response: A Focus on Liver Carcinogenesis,mma-glutamyl transferase (GGT), glucose-6-phosphate dehydrogenase (G6PD), thioredoxin reductase (TXNR), NAD(P)H dehydrogenase [quinone] 1 (NQO1), and prostaglandin reductase 1 (PTGR1). The increased expression of these enzymes is suggested as biomarker that favors tumor development by stimulating pr作者: 硬化 時(shí)間: 2025-3-28 18:17
Biomarkers to Monitor Graft Function Following Liver Transplantation,(albumin, bilirubin, prothrombin time). Novel genetic markers such as microRNAs also show potential as more accurate or specific biomarker for various types of injury and functions. Some of these serum biomarkers were shown to be promising in predicting disease or severity of injury when measured in作者: 轎車 時(shí)間: 2025-3-28 22:50 作者: cardiovascular 時(shí)間: 2025-3-29 00:35
Cortisol as Biomarkers in Cirrhosis, Child Pugh and model for end-stage liver disease scores. The diagnosis of adrenal insufficiency in cirrhosis constitutes a crucial point. Published studies have used a variety of biochemical criteria to define abnormalities in adrenal function during liver cirrhosis. Common methods used in the gene作者: 使激動 時(shí)間: 2025-3-29 05:36
,Fibrinogen α-Chain as a Serum Marker of Liver Disease,have been reproduced by different laboratories, and recently a marked downregulation of this protein fragment has also been described in the initial stages of liver fibrosis. In this chapter, we have described the potential role of fibrinogen α chain and particularly the 5.9 kDa fragment of fibrinog作者: PAN 時(shí)間: 2025-3-29 10:36 作者: cauda-equina 時(shí)間: 2025-3-29 13:35
Graft-Derived Cell-Free DNA as a Biomarker in Liver Transplantation,r more effective treatment intervention. It is especially helpful to guide changes in immunosuppression and to monitor immunosuppression minimization. This new approach may contribute to achieve more effective, less toxic personalized immunosuppression.作者: Recess 時(shí)間: 2025-3-29 19:22 作者: TATE 時(shí)間: 2025-3-29 22:32 作者: 止痛藥 時(shí)間: 2025-3-30 00:07
Hydroxyproline as a Biomarker in Liver Disease, marker for diagnosis or measurement of the anti-fibrotic activity of therapeutic interventions of herbal or non-herbal medicine argues its importance as noninvasive fibrotic detecting biomarker in chronic liver diseases with severe fibrosis.作者: 商店街 時(shí)間: 2025-3-30 06:38
https://doi.org/10.1007/978-3-7091-1519-0ant fibrosis. It showed promising results for predicting the presence of fibrosis in pediatric patients with NAFLD. Transient elastography, a noninvasive and objective but expensive method, showed higher performance in diagnosing significant fibrosis than APRI.作者: Phonophobia 時(shí)間: 2025-3-30 10:03 作者: 吹氣 時(shí)間: 2025-3-30 16:06
https://doi.org/10.1007/978-3-658-12169-3el biomarkers. Data have indicated that the combined testing of AFP, the lens culinaris agglutinin-reactive fraction of AFP (AFP-L3), or des-γ-carboxyprothrombin (DCP) could help to increase the sensitivity of diagnosis of HCC, but this approach is currently used in only a few countries, such as Jap作者: 細(xì)頸瓶 時(shí)間: 2025-3-30 17:02 作者: flourish 時(shí)間: 2025-3-30 22:04
Resharping the European Securities Industriemodeling leads to a range of formation and disease-relevant degradation products of extracellular and intracellular proteins into the circulation. These fragments may provide information about the pathogenesis of disease and serve as serological biomarker targets. Clinically there is a need to ident作者: sulcus 時(shí)間: 2025-3-31 02:01
Resharping the European Securities Industriemma-glutamyl transferase (GGT), glucose-6-phosphate dehydrogenase (G6PD), thioredoxin reductase (TXNR), NAD(P)H dehydrogenase [quinone] 1 (NQO1), and prostaglandin reductase 1 (PTGR1). The increased expression of these enzymes is suggested as biomarker that favors tumor development by stimulating pr作者: 媽媽不開心 時(shí)間: 2025-3-31 08:01
https://doi.org/10.1007/978-3-658-03051-3(albumin, bilirubin, prothrombin time). Novel genetic markers such as microRNAs also show potential as more accurate or specific biomarker for various types of injury and functions. Some of these serum biomarkers were shown to be promising in predicting disease or severity of injury when measured in作者: 議程 時(shí)間: 2025-3-31 13:14
Konservative Frakturenbehandlungdifferentiation, migration, and cell survival. Wnt/β-catenin signaling pathway is the major pathway involved in EpCAM-positive hepatic cancers. CD133 and EpCAM have several significant clinical implications in diagnosis, prognosis, and therapy of human liver cancers. Recently defined histological ty作者: esthetician 時(shí)間: 2025-3-31 15:47 作者: GLIB 時(shí)間: 2025-3-31 21:03
,Exkurs II: Die ?Neue Rechte“ in Frankreich,have been reproduced by different laboratories, and recently a marked downregulation of this protein fragment has also been described in the initial stages of liver fibrosis. In this chapter, we have described the potential role of fibrinogen α chain and particularly the 5.9 kDa fragment of fibrinog作者: intuition 時(shí)間: 2025-3-31 22:32 作者: 磨碎 時(shí)間: 2025-4-1 05:00
,Behandlung der Menstruationsst?rungen,r more effective treatment intervention. It is especially helpful to guide changes in immunosuppression and to monitor immunosuppression minimization. This new approach may contribute to achieve more effective, less toxic personalized immunosuppression.作者: Ovulation 時(shí)間: 2025-4-1 09:35
https://doi.org/10.1007/978-3-662-02089-0. In addition, Hepascore is dynamic over time and has been demonstrated to predict adverse clinical outcomes in longitudinal cohorts of chronic hepatitis C and alcoholic liver disease patients. Thus, Hepascore is a valuable clinical tool to stage liver fibrosis and determine prognosis, need for trea作者: 傷心 時(shí)間: 2025-4-1 12:48 作者: 濕潤 時(shí)間: 2025-4-1 14:35 作者: 假設(shè) 時(shí)間: 2025-4-1 18:46
Living reference work 20200th edition that have been used to identify markers of disease and is suggested that there may be as manyas 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of mar作者: Prostaglandins 時(shí)間: 2025-4-2 00:09 作者: Brochure 時(shí)間: 2025-4-2 04:47 作者: CORE 時(shí)間: 2025-4-2 08:35
